These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5062969)

  • 1. Performance tests in a study of phenothiazines in schizophrenia: caveats and conclusions.
    Schooler NR; Goldberg SC
    Psychopharmacologia; 1972; 24(1):81-98. PubMed ID: 5062969
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of improvement in schizophrenia under four phenothiazines.
    Goldberg SC; Mattsson N; Cole JO; Klerman GL
    Arch Gen Psychiatry; 1967 Jan; 16(1):107-17. PubMed ID: 6066689
    [No Abstract]   [Full Text] [Related]  

  • 4. Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.
    Schooler NR; Boothe H; Goldberg SC
    Arch Gen Psychiatry; 1971 Aug; 25(2):138-47. PubMed ID: 5106102
    [No Abstract]   [Full Text] [Related]  

  • 5. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
    Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in primary process expression in hospitalized schizophrenics treated with phenothiazines: two projective tasks compared.
    Ebert JN; Ewing JH; Rogers MH; Reynolds DJ
    J Genet Psychol; 1977 Mar; 130(1st Half):83-94. PubMed ID: 16082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in gustatory acuity and hyperarousal in schizophrenia.
    Fischer R; Ristine LP; Wisecup P
    Biol Psychiatry; 1969 Jul; 1(3):209-18. PubMed ID: 4390893
    [No Abstract]   [Full Text] [Related]  

  • 8. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC; Mattsson NB
    Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
    Dis Nerv Syst; 1967 Jun; 28(6):369-83. PubMed ID: 5342391
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.
    Goldberg SC; Frosch WA; Drossman AK; Schooler NR; Johnson GF
    Arch Gen Psychiatry; 1972 Apr; 26(4):367-73. PubMed ID: 4552130
    [No Abstract]   [Full Text] [Related]  

  • 11. A trial of fluphenazine enanthate in chronic schizophrenia.
    Millar J; Daniel GR
    Br J Psychiatry; 1967 Dec; 113(505):1431-2. PubMed ID: 4865296
    [No Abstract]   [Full Text] [Related]  

  • 12. Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time.
    Goldberg SC; Schooler NR; Mattsson N
    J Nerv Ment Dis; 1967 Aug; 145(2):158-62. PubMed ID: 4861752
    [No Abstract]   [Full Text] [Related]  

  • 13. Maintenance treatment of schizophrenia with long-acting fluphenazine.
    Niturad A; Ciurezu T; Cucu I
    Act Nerv Super (Praha); 1974 Aug; 16(3):167. PubMed ID: 4154028
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenothiazine effects in good premorbid schizophrenics divided into paranoid-nonparanoid status.
    Judd LL; Goldstein MJ; Rodnick EH; Jackson NL
    Arch Gen Psychiatry; 1973 Aug; 29(2):207-21. PubMed ID: 4582360
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
    Keskiner A; Itil TM; Todt N
    Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of chlorpromazine and fluphenazine on some schizophrenic forms of behaviour.
    Jovanović T; Marković A
    Br J Psychiatry; 1972 Feb; 120(555):223-4. PubMed ID: 5043728
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug treatment in newly admitted schizophrenic patients.
    Clark ML; Huber WK; Charalampous KD; Serafetinides EA; Trousdale W; Colmore JP
    Arch Gen Psychiatry; 1971 Nov; 25(5):404-9. PubMed ID: 4943915
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Baclofen in the treatment of schizophrenia.
    Frederiksen PK
    Lancet; 1975 Mar; 1(7908):702. PubMed ID: 47138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.